title: [Fournier gangrene: evaluation of prognostic factors in 90 patients].
abstract: BACKGROUND
  This study evaluates the risk factors and prognostic variables that affect survival of patients with gangrene of Fournier.
  
  
  METHODS
  The study retrospectively analyzed 90 consecutive patients with gangrene of Fournier treated in our institution between 1975 and 2008. We evaluated the average age, associated systemic diseases, and the source, time of evolution and extent of necrotizing fasciitis. The outcomes were assessed according to whether the patient survived or died. All patients had aggressive surgical debridement, and received parenteral antibiotic therapy.
  
  
  RESULTS
  The mortality rate was 34.4%. The mean age was 63.0 years (range 33-95), a statistically significant difference was found between the age of the survivors (median age, 59.84 years) and those who died (median age, 70.20 years) (p = 0.001). Medical comorbidities were identified in 51 patients; the death rate was higher in patients who had any medical disease, especially those who suffered from cancer. Although diabetes mellitus was the most common associated pathology, it was not related to a statistically significant worst prognosis. The source of the infection was identified in 62 patients, who showed a higher mortality (p = 0.015), the mortality rate when a urological source is identified was 50%. Moreover, patients suffering from a more extensive necrotizing infection showed a worst prognosis.
  
  
  CONCLUSIONS
  The gangrene of Fournier has a high mortality rate. Large series are required to study prognostic variables of this disease. The patient age, the presence of systemic risk factors, especially cancer, a urological source of infection and the extent of the disease have impact on the prognosis of Fournier's gangrene.
authors.affiliation: Servicio de Urología, Hospital Universitario 12 de Octubre, Madrid. josemedinapolo@telefonica.net
authors.forename: J
authors.initials: J
authors.lastname: Medina Polo
authors.forename: A
authors.initials: A
authors.lastname: Tejido Sánchez
authors.forename: F
authors.initials: F
authors.lastname: de la Rosa Kehrmann
authors.forename: N
authors.initials: N
authors.lastname: Felip Santamaría
authors.forename: M
authors.initials: M
authors.lastname: Blanco Alvarez
authors.forename: O
authors.initials: O
authors.lastname: Leiva Galvis
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D018934:Fournier Gangrene / Q000401:mortality* / Q000628:therapy; D005832:Genital Diseases, Male / Q000401:mortality* / Q000628:therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012189:Retrospective Studies; D012307:Risk Factors